PRESS RELEASE published on 03/25/2025 at 15:18, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Spirent Communications PLC The Vanguard Group, Inc. discloses a 5.12% position in Spirent Communications plc as of 24th March 2025. Details in compliance with Rule 8.3 of the Takeover Code Position Disclosure Takeover Code Vanguard Group Financial Securities Spirent Communications
PRESS RELEASE published on 03/25/2025 at 15:16, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Renewi PLC The Vanguard Group, Inc. discloses 1.40% interest in Renewi plc's 100p ordinary securities. Sale of 5,643 shares at 8.54 GBP per unit on 24 March 2025 Securities Disclosure The Vanguard Group Renewi Plc Sale
BRIEF published on 03/25/2025 at 15:16, 1 year 5 months ago The Vanguard Group's Disclosure on Life Science Reit PLC Form 8.3 Disclosure The Vanguard Group Takeover Code Life Science REIT
PRESS RELEASE published on 03/25/2025 at 15:15, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Primary Health Properties PLC The Vanguard Group, Inc. files Form 8.3 disclosure for Primary Health Properties PLC, revealing ownership of 5.59% of securities, recent transactions, and related parties Securities Form 8.3 Disclosure Vanguard Group Primary Health Properties Plc
PRESS RELEASE published on 03/25/2025 at 15:14, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: PRS REIT Plc/The The Vanguard Group, Inc. discloses a 1.76% stake in PRS REIT Plc/The as of 24 March 2025. Details in Form 8.3 filing Form 8.3 Financial Dealings Vanguard Group Stake Disclosure PRS REIT Plc
BRIEF published on 03/25/2025 at 15:14, 1 year 5 months ago The Vanguard Group, Inc.: Position Disclosure on John Wood Group PLC Position Disclosure Takeover Code Vanguard Group Securities Trading John Wood Group
PRESS RELEASE published on 03/25/2025 at 15:11, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: Life Science Reit PLC The Vanguard Group, Inc. discloses a 1.00% interest in Life Science Reit PLC's 1p ordinary shares through Form 8.3. Dealings include sale of 1,477 securities at 0.46 GBP per unit Securities Form 8.3 Vanguard Group Sale Life Science REIT
BRIEF published on 03/25/2025 at 15:11, 1 year 5 months ago The Vanguard Group's Position on Greencore Group PLC Shares Takeover Code Vanguard Group Stock Transactions Equity Disclosure Greencore Shares
BRIEF published on 03/25/2025 at 15:09, 1 year 5 months ago The Vanguard Group Discloses Position in Dowlais Group PLC The Vanguard Group Takeover Code Rule 8.3 Disclosure Securities Position Dowlais Group Plc
PRESS RELEASE published on 03/25/2025 at 15:09, 1 year 5 months ago Form 8.3 - The Vanguard Group, Inc.: John Wood Group PLC The Vanguard Group, Inc. discloses 4.56% stake in John Wood Group PLC as of 24 March 2025. Transactions include purchases and sales of 4 2/7 p ordinary shares Transactions The Vanguard Group Stake Disclosure John Wood Group PLC 4 2/7 P Ordinary Shares
Published on 09/14/2026 at 12:00, 46 minutes ago Banyan Gold to be Added to the GDXJ, the VanEck Junior Gold Miners ETF
Published on 09/14/2026 at 11:30, 1 hour 16 minutes ago FireFox Gold Drills High-Grade and Visible Gold, including 7m @ 11.36 g/t Gold, in Northeast Zone Step-out Hole and Finds New Extensions at the Central Zone, Mustajärvi Project, Lapland, Finland
Published on 09/14/2026 at 08:02, 4 hours 44 minutes ago Southern Energy Corp. Announces Rig Release of Cotton Valley Test Well at Williamsburg
Published on 09/14/2026 at 08:00, 4 hours 46 minutes ago Caledonia Mining Corporation Plc: Capital Markets Day Update
Published on 09/14/2026 at 08:00, 4 hours 46 minutes ago Touchstone Exploration Announces Operational Update
Published on 09/14/2026 at 12:30, 16 minutes ago Zerova to bring its MCS dispenser to Europe at IAA Transportation 2026
Published on 09/14/2026 at 12:30, 16 minutes ago Restoration - The Hospital Company (Dartford) Issuer PLC
Published on 09/14/2026 at 12:10, 36 minutes ago ISS upgrades INDUS Holding AG’s ESG rating to ‘B - ’
Published on 09/11/2026 at 07:00, 3 days 5 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 17 hours ago Availability of the 2026 Interim Financial Report
